Nuvectis Pharma, Inc. (NVCT)
NASDAQ: NVCT · Real-Time Price · USD
8.73
+0.27 (3.19%)
At close: Apr 14, 2026, 4:00 PM EDT
8.74
+0.01 (0.11%)
After-hours: Apr 14, 2026, 4:10 PM EDT
Nuvectis Pharma Market Cap
Nuvectis Pharma has a market cap or net worth of $231.27 million as of April 14, 2026. Its market cap has increased by 2.46% in one year.
Market Cap
231.27M
Enterprise Value
199.64M
1-Year Change
2.46%
Ranking
Category
Stock Price
$8.73
Market Cap Chart
Since the IPO on February 4, 2022, Nuvectis Pharma's market cap has increased from $58.01M to $231.27M, an increase of 298.71%. That is a compound annual growth rate of 39.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 13, 2026 | 224.12M | 15.89% |
| Dec 31, 2025 | 193.39M | 85.02% |
| Dec 31, 2024 | 104.53M | -27.67% |
| Dec 29, 2023 | 144.50M | 31.58% |
| Dec 30, 2022 | 109.82M | 89.32% |
| Feb 4, 2022 | 58.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arcturus Therapeutics Holdings | 239.32M |
| Eledon Pharmaceuticals | 236.25M |
| ALX Oncology Holdings | 229.66M |
| Voyager Therapeutics | 228.56M |
| MediWound | 224.27M |
| MacroGenics | 219.27M |
| Context Therapeutics | 215.00M |
| Keros Therapeutics | 213.34M |